ACAD

ACADIA Pharmaceuticals Inc. (ACAD) Reports 2Q15 Financial Results

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and …

Corey Williams — August 6, 2015, 4:27 PM EDT

Company Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Announces Publication of Data from Its -015 Open Label Safety Study in Parkinson’s Disease Psychosis in the JAMDA

Corey Williams — August 6, 2015, 9:06 AM EDT

Stock Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Announces Senior Management Appointments in Manufacturing, Quality, Compliance, Access and Reimbursement and Business Development

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological …

Corey Williams — August 5, 2015, 9:16 AM EDT

H.C. Wainwright Maintains Buy on ACADIA Pharmaceuticals Inc. Following Meeting with Management

In a research report issued yesterday, H.C.

Jason Cohen — July 2, 2015, 4:08 PM EDT

Company Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Presents Data from Its Phase III Program with NUPLAZID™ for Parkinson’s Disease Psychosis

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system …

Corey Williams — June 16, 2015, 9:09 AM EDT

Needham Maintains Buy on ACADIA Pharmaceuticals Inc.; Here’s Why

In a research report released Friday, Needham analyst Alan Carr maintained a Buy rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a $38 price target, after the …

Jason Cohen — May 8, 2015, 2:36 PM EDT

Stock Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Reports First Quarter 2015 Financial Results

Corey Williams — May 7, 2015, 4:09 PM EDT

Stock Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, …

Corey Williams — April 7, 2015, 9:04 AM EDT